mRNA

News

Lilly joins cancer vaccine race with CureVac alliance

Lilly has signed a deal with CureVac to develop up to five next-generation cancer vaccines which use messenger RNA (mRNA) technology.

Events

Partner Content

RNA Therapeutics 2018

Partner Content

Introducing the 9th Annual RNA Therapeutics 2018

RNA Therapeutics

News

AZ signs pact with mRNA specialists Ethris in respiratory di...

AstraZeneca has signed a five-year strategic research collaboration with Ethris, an mRNA-based therapeutics company specialising in pulmonary disease.

News

AstraZeneca spends $240m on Moderna mRNA drugs; cuts even mo...

Pascal Soriot announces further restructuring plans for AstraZeneca, including additional sales job cuts and an external million-dollar partnership with Moderna Therapeutics. Pascal Soriot, AstraZeneca’s CEO, has announced further plans to turn around the drugmaker’s problems and...

Lilly joins cancer vaccine race with CureVac alliance

RNA Therapeutics 2018

Introducing the 9th Annual RNA Therapeutics 2018

AZ signs pact with mRNA specialists Ethris in respiratory di...

AstraZeneca spends $240m on Moderna mRNA drugs; cuts even mo...

Consolidating data strategy for global success: Insights fro...

How to meet your physicians where they are online

mRNA

Editor's Picks